Discover 774 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 774
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Location: Norwich CT, Guilford CT, North Haven CT, New Haven CT,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase 1, Phase 2, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Boston MA, Quebec, New York NY, Morristown NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase 3, Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Newark DE, Baltimore MD, Washington D.C. DC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Boston MA, Worcester MA, Lebanon NH, New York NY,
Sponsor: Cook Research Incorporated
Sex: All
Age: 18+
Code: NCT04875429
Recruiting
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Location: Washington D.C. DC, Fairfax VA, Plantation FL,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07407933
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
for
Advanced Renal Cell Carcinoma (RCC)
Location: New York NY, Baltimore MD, Washington D.C. DC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07293351
Phase 1, Phase 2, Recruiting
IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction
for
Provoked Vestibulodynia
Location: New York NY, Washington D.C. DC
Sponsor: Center for Vulvovaginal Disorders
Sex: Female
Age: 18+
Code: NCT07486830
Phase 2, Recruiting
Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia
for
Second Hand Tobacco Smoke
Location: Washington D.C. DC
Sponsor: George Washington University
Sex: All
Age: 18+
Code: NCT06166433
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
for
Healthy Adults
Location: Milford CT, Philadelphia PA, Washington D.C. DC,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07431853
Phase 2, Recruiting
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
for
Fabry Disease, Pregnancy, Pregnancy Complications
Location: Washington D.C. DC
Sponsor: Chiesi Farmaceutici S.p.A.
Sex: Female
Age: 0+
Code: NCT06941025
Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Boston MA, New Hyde Park NY, New York NY, Hackensack NJ,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase 3, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Stony Brook NY, Lake Success NY, Manhasset NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
for
Sickle Cell Disease Vaso-occlusive Crisis
Location: The Bronx NY, New York NY, Baltimore MD, Greenville NC,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT06699849
Phase 2, Recruiting
The ArtixASCEND Study
for
Acute Lower Limb Arterial Occlusion
Location: Boston MA, New Haven CT, Stony Brook NY, Brooklyn NY,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT07135895
Recruiting
A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
for
Neurofibromatosis Type 1
Location: Washington D.C. DC, Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 70+
Code: NCT06507748
Recruiting
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
for
Advanced Renal Cell Carcinoma (aRCC),
Location: Hershey PA, Washington D.C. DC, Chapel Hill NC,
Sponsor: Brian Rini
Sex: All
Age: 18+
Code: NCT07188896
Phase 2, Recruiting
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
for
Status Epilepticus
Location: New Haven CT, Philadelphia PA, Wilmington DE,
Sponsor: University of Virginia
Sex: All
Age: 1+
Code: NCT06907173
Phase 3, Recruiting
FORWARD CAD IDE Study
for
Coronary Arterial Disease (CAD)
Location: Boston MA, Hartford CT, Roslyn NY, New York NY, York PA,